A detailed history of Jane Street Group, LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 134,390 shares of RMTI stock, worth $279,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,390
Holding current value
$279,531
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.67 - $4.4 $224,431 - $591,316
134,390 New
134,390 $533,000
Q4 2023

Feb 14, 2024

BUY
$1.58 - $2.44 $9,726 - $15,020
6,156 Added 23.57%
32,279 $61,000
Q3 2023

Nov 14, 2023

SELL
$1.83 - $6.19 $450,522 - $1.52 Million
-246,187 Reduced 90.41%
26,123 $54,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $5.46 $490,158 - $1.49 Million
272,310 New
272,310 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$1.2 - $2.11 $25,263 - $44,421
21,053 New
21,053 $28,000
Q3 2022

Nov 14, 2022

BUY
$1.2 - $2.11 $25,263 - $44,421
21,053 New
21,053 $28,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $22.2M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.